C&Y Pharmaceutical
3002547.833.85% ( +0.29 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: C&Y Pharmaceutical(300254) the Revenue is 173.8 M (-4.37%);the EBIT is 10.13 M (-33.74%);the EPS is 0.0135 (-68.38%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.17B4.37%
----
----
EBIT
0.01B33.74%
----
----
EPS
0.013568.38%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf